These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 28252822

  • 21. The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas.
    Yao R, Cheng A, Liu M, Zhang Z, Jin B, Yu H.
    J Comput Assist Tomogr; ; 45(2):269-276. PubMed ID: 33346568
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel 1H-MRS Applied to Brain Tumor Analysis.
    Dou W, Zhang M, Zhang X, Li Y, Chen H, Li S, Lu M, Dai J, Constans JM.
    PLoS One; 2015; 10(9):e0137850. PubMed ID: 26367871
    [Abstract] [Full Text] [Related]

  • 24. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma.
    Li L, Chen W, Yan Z, Feng J, Hu S, Liu B, Liu X.
    J Magn Reson Imaging; 2020 Nov; 52(5):1487-1496. PubMed ID: 32524685
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
    Anselmi M, Catalucci A, Felli V, Vellucci V, Di Sibio A, Gravina GL, Di Staso M, Di Cesare E, Masciocchi C.
    Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
    [Abstract] [Full Text] [Related]

  • 27. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS, Ahn SS, Lee SK, Chang JH, Kang SG, Kim SH, Zhou J.
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [Abstract] [Full Text] [Related]

  • 28. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, Tomandl B, Moser E, Ganslandt O.
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [Abstract] [Full Text] [Related]

  • 29. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C, Liu C, Zhao L, Jiang J, Zhang J, Li S, Zhu W, Wang J.
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [Abstract] [Full Text] [Related]

  • 30. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
    Ma B, Blakeley JO, Hong X, Zhang H, Jiang S, Blair L, Zhang Y, Heo HY, Zhang M, van Zijl PC, Zhou J.
    J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
    [Abstract] [Full Text] [Related]

  • 31. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N, Morales H, Modrego PJ, Pina MA.
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [Abstract] [Full Text] [Related]

  • 32. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR, Carr RB, Matsusue E, Iyer RS, Rockhill JK, Haynor DR, Maravilla KR.
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [Abstract] [Full Text] [Related]

  • 33. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH.
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [Abstract] [Full Text] [Related]

  • 34. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S.
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [Abstract] [Full Text] [Related]

  • 35. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX.
    Chin Med J (Engl); 2009 Jan 05; 122(1):39-43. PubMed ID: 19187615
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C, Hattingen E, Pilatus U, Franz K, Schänzer A, Lanfermann H, Seifert V, Gasser T.
    Neurosurgery; 2009 Nov 05; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [Abstract] [Full Text] [Related]

  • 37. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.
    Invest Radiol; 2013 May 05; 48(5):295-301. PubMed ID: 23296081
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
    Qamar S, King AD, Ai QH, Mo FKF, Chen W, Poon DMC, Tong M, Ma BB, Yeung DK, Wang YX, Yuan J.
    Eur Radiol; 2020 Nov 05; 30(11):6339-6347. PubMed ID: 32588210
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.